Posts By: Gubba Group

Bayer’s Monsanto, India’s NSL settle long-running GM cotton seed dispute

March 31, 2021 Gubba Seed In E News

Bayer AG said it had reached an “amicable settlement” in its Monsanto unit’s long-running intellectual property dispute with Indian seed maker Nuziveedu Seeds Ltd (NSL)...

Continue Reading

A new tool that instantly detects antibiotics in milk

March 31, 2021 Gubba Frozen In E News

Exposure to OTC can result in the development of antimicrobial resistance in humans or even adverse health effects. A team of researchers from the Hyderabad-based...

Continue Reading

Hyderabad Man Helps 45000 Farmers Turn To Organic Farming, Increase Income By 30%

March 31, 2021 Gubba Frozen In E News

Raj Seelam from Hyderabad founded Sresta Natural Bioproducts to encourage farmers to grow organic food, which he sells under the brand 24 Mantra to help...

Continue Reading

Don’t let GM technology die

March 31, 2021 Gubba Seed In E News

Activists and those with vested interests are blocking the technology that will help farmers The status of GM crops in India is like that of...

Continue Reading

Bayer’s Monsanto, India’s NSL settle long-running GM cotton seed dispute

March 31, 2021 Gubba Seed In E News

Bayer AG said it had reached an “amicable settlement” in its Monsanto unit’s long-running intellectual property dispute with Indian seed maker Nuziveedu Seeds Ltd (NSL)...

Continue Reading

Spray created in Estonia may help prevent corona infection

March 31, 2021 Gubba Pharma In E News

In cooperation between Estonian companies and the University of Tartu and the Estonian University of Life Sciences, technology has been developed for producing nasal and...

Continue Reading

Kiran Mazumdar-Shaw: India’s First Lady Of Biotech

March 31, 2021 Gubba Pharma In E News

A blockbuster drug is not about a billion dollars, but a billion patients. This is one of the maxims of Kiran Mazumdar-Shaw, founder of Biocon,...

Continue Reading

Covovax trials begin in India, hope to launch it by Sept : Adar Poonawalla

March 31, 2021 Gubba Pharma In E News

In August 2020, US-based vaccine maker Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its Covid-19 vaccine...

Continue Reading

Beacon may ship $5m pharma products to Syria

March 24, 2021 Gubba Pharma In E News

Beacon Pharmaceuticals, the local pioneer of oncology product manufacturing, may export $5 million worth of pharmaceuticals to Syria by December this year — a huge...

Continue Reading